We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CCEL market cap is 61.27M. The company's latest EPS is USD -1.1811 and P/E is -5.67.
| Quarter End | Aug 2023 | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 7.87M | 8.93M | 7.85M | 8.04M | 8.07M |
| Operating Income | 1.29M | -12.37M | 816k | 1.7M | 1.4M |
| Net Income | 680k | -11.19M | 556k | 656k | 1.05M |
| Year End 30 November 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 32.56M | 33.09M | 29.67M | 30.34M | 32.39M |
| Operating Income | 7.4M | 8.95M | 5.17M | 4.03M | -8.57M |
| Net Income | 2.29M | 3.63M | 2.08M | 2.77M | -9.52M |
| Quarter End | Aug 2023 | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 69.8M | 61.22M | 61.71M | 62.57M | 62.93M |
| Total Liabilities | 69.81M | 72.25M | 72.05M | 73.31M | 72.49M |
| Total Equity | -16k | -11.03M | -10.34M | -10.74M | -9.56M |
| Year End 30 November 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 42.89M | 46.2M | 60.66M | 64.89M | 61.22M |
| Total Liabilities | 49.84M | 48.87M | 56.48M | 66.41M | 72.25M |
| Total Equity | -6.95M | -2.67M | 4.18M | -1.52M | -11.03M |
| Quarter End | Aug 2023 | Nov 2023 | Feb 2024 | May 2024 | Aug 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 5.58M | 8.92M | -356k | 1.42M | 3.85M |
| Investing | -6.16M | -8.15M | -342k | -3.1M | -3.76M |
| Financing | -533k | -2.07M | 539k | 1.74M | -302k |
| Year End 30 November 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 6.32M | 8.47M | 7.93M | 8.57M | 8.92M |
| Investing | -690k | 357k | -6.95M | -15.28M | -8.15M |
| Financing | -5.13M | -5M | -3.07M | 148k | -2.07M |
| Market Cap | 61.27M |
| Price to Earnings Ratio | -5.67 |
| Price to Sales Ratio | 1.67 |
| Price to Cash Ratio | 132.94 |
| Price to Book Ratio | -4.9 |
| Dividend Yield | 13.16% |
| Shares Outstanding | 8.06M |
| Average Volume (1 week) | 7.83k |
| Average Volume (1 Month) | 14.71k |
| 52 Week Change | 50.50% |
| 52 Week High | 9.498 |
| 52 Week Low | 4.475 |
| Spread (Intraday) | 0.75 (9.38%) |
| Company Name | Cryo Cell International Inc |
| Address |
874 walker road dover, delaware 19904 |
| Website | https://www.cryo-cell.com |
| Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
